Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line

S P Cole1, G Bhardwaj, J H Gerlach

  • 1Cancer Research Laboratories, Queen's University, Kingston, Ontario, Canada.

Science (New York, N.Y.)
|December 4, 1992
PubMed

Insights

Lung cancer cells resistant to chemotherapy overexpress a novel ATP-binding cassette transporter. Gene amplification on chromosome 16 correlates with this overexpression and drug resistance, offering new therapeutic targets.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • Doxorubicin-selected H69AR lung cancer cells exhibit resistance to multiple chemotherapeutic agents.
  • This resistance is not mediated by P-glycoprotein, a common multidrug resistance transporter.
  • Understanding novel resistance mechanisms is crucial for developing effective lung cancer therapies.

Purpose of the Study:

  • To identify and characterize novel genes and mechanisms conferring multidrug resistance in lung cancer.
  • To investigate the genetic basis of drug resistance in the H69AR cell line.

Main Methods:

  • Isolation of complementary DNA (cDNA) clones corresponding to overexpressed messenger RNAs (mRNAs) in H69AR cells.
  • Analysis of mRNA expression levels using hybridization techniques.
  • Gene amplification analysis via chromosomal mapping (chromosome 16, band p13.1).
  • Correlation of gene amplification and mRNA expression with drug sensitivity.

Main Results:

  • A novel mRNA (7.8–8.2 kilobases) was found to be 100- to 200-fold overexpressed in H69AR cells compared to parental H69 cells.
  • This overexpression was linked to amplification of the cognate gene on chromosome 16 at band p13.1.
  • Reversion to drug sensitivity correlated with decreased mRNA expression and loss of gene amplification.
  • The identified mRNA encodes a member of the ATP-binding cassette (ABC) transmembrane transporter superfamily.

Conclusions:

  • A novel ATP-binding cassette transporter, overexpressed due to gene amplification on chromosome 16, contributes to multidrug resistance in lung cancer.
  • This finding provides a new molecular target for overcoming chemotherapy resistance in lung cancer.

Related Concept Videos

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...